• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND VALIANT CAPTIVIA - FF; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND VALIANT CAPTIVIA - FF; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number VAMF4444C200TJ
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Aneurysm (1708); Seroma (2069)
Event Date 03/24/2016
Event Type  Injury  
Manufacturer Narrative
Other relevant device(s) are: vamf4440c150tj sn (b)(4), expiration date: (b)(6) 2018, udi # (b)(4), vamf4646c200tj sn (b)(4), expiration date: (b)(4) 2017, udi # (b)(4).A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
A valiant captivia stent graft system was implanted in a patient for the endovascular treatment of a 6.0 cm thoracic aortic aneurysm.The patient had an aortic arch replacement at some point prior to the index procedure.An elephant trunk tevar was performed and another manufacturer's stent graft was also implanted during the index procedure.Approximately eight months post index procedure it was noted that the distal side of the valiant device had become aneurysmal.The physician elected to implant two additional valiant devices that had to be implanted above the celiac artery.It was noted that there were no junctional leaks.The patient remained under observation after this procedure.The aneurysm then began growing larger increasing the risk of rupture.A left thoracotomy was performed and all the valiant devices, as well as part of the other manufacture¿s device, were explanted.A blood vessel prosthesis was then implanted.The physician stated that the cause of the event was a seroma that began to appear from an unknown location; it was unknown if the stent graft was related to the seroma.The patient was stable, recovering and no additional intervention was required.No additional clinical sequelae were reported and the patient is fine.
 
Manufacturer Narrative
Corrected information: sex, date of birth.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VALIANT CAPTIVIA - FF
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer Contact
paola garnica
3576 unocal place
santa rosa, CA 95403
7075661361
MDR Report Key6498242
MDR Text Key72950974
Report Number2953200-2017-00608
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P100040
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 10/17/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date11/12/2015
Device Model NumberVAMF4444C200TJ
Device Catalogue NumberVAMF4444C200TJ
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/24/2017
Initial Date FDA Received04/17/2017
Supplement Dates Manufacturer Received03/24/2017
Supplement Dates FDA Received10/17/2017
Date Device Manufactured11/12/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age67 YR
-
-